SPRO Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2024-02-01 | Keutzer Timothy | officer: Chief Operating Officer | 565,021 | A-Award | A | 239,731 | 0.00 | 0.00 |
2024-02-02 | Keutzer Timothy | officer: Chief Operating Officer | 534,050 | S-Sale | D | 30,971 | 1.36 | 42,121.00 |
2024-02-02 | Mahadevia Ankit | director | 744,997 | S-Sale | D | 63,795 | 1.37 | 87,399.00 |
2024-02-01 | JOSEPH TAMARA L | officer: Chief Legal Officer | 562,521 | A-Award | A | 239,731 | 0.00 | 0.00 |
2024-02-02 | JOSEPH TAMARA L | officer: Chief Legal Officer | 531,615 | S-Sale | D | 30,906 | 1.37 | 42,341.00 |
2024-02-01 | HAMED KAMAL | officer: Chief Medical Officer | 816,192 | A-Award | A | 239,731 | 0.00 | 0.00 |
2024-02-02 | HAMED KAMAL | officer: Chief Medical Officer | 788,117 | S-Sale | D | 28,075 | 1.37 | 38,463.00 |
2024-02-01 | Rajavelu Esther | officer: See Remarks | 419,866 | A-Award | A | 119,866 | 0.00 | 0.00 |
2024-02-01 | Shukla Sath | director, officer: CEO and President | 1,252,001 | A-Award | A | 679,501 | 0.00 | 0.00 |
2024-02-02 | Shukla Sath | director, officer: CEO and President | 1,221,100 | S-Sale | D | 30,901 | 1.37 | 42,334.00 |
2024-02-05 | Shukla Sath | director, officer: CEO and President | 1,176,007 | S-Sale | D | 45,093 | 1.45 | 65,385.00 |
2024-01-02 | Tregoning Kathleen | director | 35,604 | A-Award | A | 35,604 | 1.52 | 54,118.00 |
2023-11-13 | Rajavelu Esther | officer: See Remarks | 300,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
2023-11-06 | Rajavelu Esther | 0 | 0 | 0.00 | 0.00 | |||
2023-10-05 | Pottage John C Jr | director | 35,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2023-10-05 | Smith Cynthia | director | 35,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2023-10-05 | THOMAS FRANK E | director | 35,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2023-10-05 | Deshpande Milind | director | 51,454 | A-Award | A | 20,000 | 0.00 | 0.00 |
2023-10-05 | Tregoning Kathleen | director | 35,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2023-10-05 | VINK PATRICK V.J.J. | director | 35,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2023-10-05 | Jackson Scott Thomas | director | 35,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2023-10-05 | Mahadevia Ankit | director | 808,792 | A-Award | A | 20,000 | 0.00 | 0.00 |
2023-09-13 | HAMED KAMAL | officer: Chief Medical Officer | 576,461 | S-Sale | D | 39,496 | 1.27 | 50,160.00 |
2023-08-28 | Keutzer Timothy | officer: Chief Development Officer | 325,290 | S-Sale | D | 1,854 | 1.26 | 2,336.00 |
2023-08-28 | JOSEPH TAMARA L | officer: Chief Legal Officer | 322,790 | S-Sale | D | 1,854 | 1.26 | 2,336.00 |
2023-08-28 | Mahadevia Ankit | director | 788,792 | S-Sale | D | 9,040 | 1.26 | 11,390.00 |
2023-08-28 | Shukla Sath | director, officer: CEO and President | 576,663 | S-Sale | D | 1,854 | 1.26 | 2,336.00 |
2023-08-29 | Shukla Sath | director, officer: CEO and President | 572,500 | S-Sale | D | 4,163 | 1.30 | 5,412.00 |
2023-08-01 | Shukla Sath | director, officer: CEO and President | 578,517 | A-Award | A | 266,000 | 0.00 | 0.00 |
2023-07-15 | DiPalma Stephen J. | 0 | 0 | 0.00 | 0.00 | |||
2023-06-12 | HAMED KAMAL | officer: Chief Medical Officer | 615,957 | A-Award | A | 140,000 | 0.00 | 0.00 |
2023-02-03 | Mahadevia Ankit | director, officer: CEO and President | 797,832 | S-Sale | D | 12,286 | 1.81 | 22,238.00 |
2023-02-01 | Keutzer Timothy | officer: Chief Operating Officer | 330,538 | A-Award | A | 265,957 | 0.00 | 0.00 |
2023-02-02 | Keutzer Timothy | officer: Chief Operating Officer | 327,144 | S-Sale | D | 3,394 | 1.86 | 6,313.00 |
2023-02-01 | JOSEPH TAMARA L | officer: Chief Legal Officer | 328,038 | A-Award | A | 265,957 | 0.00 | 0.00 |
2023-02-02 | JOSEPH TAMARA L | officer: Chief Legal Officer | 324,644 | S-Sale | D | 3,394 | 1.86 | 6,313.00 |
2023-02-01 | Shukla Sath | officer: Chief Financial Officer | 322,021 | A-Award | A | 265,957 | 0.00 | 0.00 |
2023-02-02 | Shukla Sath | officer: Chief Financial Officer | 312,517 | S-Sale | D | 9,504 | 1.83 | 17,372.00 |
2023-02-01 | HAMED KAMAL | officer: Chief Medical Officer | 475,957 | A-Award | A | 265,957 | 0.00 | 0.00 |
2023-02-01 | Mahadevia Ankit | director, officer: CEO and President | 810,118 | A-Award | A | 531,914 | 0.00 | 0.00 |
2023-01-03 | Tregoning Kathleen | director | 30,943 | A-Award | A | 30,943 | 1.29 | 39,916.00 |
2023-01-03 | VINK PATRICK V.J.J. | director | 15,471 | A-Award | A | 15,471 | 1.29 | 19,958.00 |
2022-11-07 | GSK PLC | director | 9,190,606 | I | 0 | 0.00 | 0.00 | |
2022-09-22 | Aquilo Capital Management, LLC | 10 percent owner | 3,985,719 | S-Sale | D | 1,335,512 | 2.25 | 3,005,303.00 |
2022-09-22 | Aquilo Capital Management, LLC | 10 percent owner | 3,419,435 | S-Sale | D | 566,284 | 2.25 | 1,274,309.00 |
2022-09-15 | Jackson Scott Thomas | director | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
2022-09-15 | Deshpande Milind | director | 31,454 | A-Award | A | 15,000 | 0.00 | 0.00 |
2022-09-15 | Pottage John C Jr | director | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
2022-09-15 | Smith Cynthia | director | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
2022-09-15 | Tregoning Kathleen | director | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
2022-08-29 | Shukla Sath | officer: Chief Financial Officer | 56,064 | S-Sale | D | 6,017 | 0.89 | 5,378.00 |
2022-04-26 | Aquilo Capital Management, LLC | 10 percent owner | 5,321,231 | P-Purchase | A | 39,727 | 5.24 | 207,971.00 |
2022-04-26 | Aquilo Capital, L.P. | director: | 5,321,231 | P-Purchase | A | 39,727 | 5.24 | 207,971.00 |
2022-03-30 | Aquilo Capital Management, LLC | 10 percent owner | 5,281,504 | P-Purchase | A | 16,885 | 8.79 | 148,392.00 |
2022-03-30 | Aquilo Capital, L.P. | director: | 5,264,619 | P-Purchase | A | 33,115 | 8.79 | 291,028.00 |
2022-03-30 | Aquilo Capital Management, LLC | 10 percent owner | 5,264,619 | P-Purchase | A | 33,115 | 8.79 | 291,028.00 |
2022-03-14 | Aquilo Capital, L.P. | director: | 5,231,504 | P-Purchase | A | 8,006 | 7.63 | 61,054.00 |
2022-03-14 | Aquilo Capital Management, LLC | 10 percent owner | 5,231,504 | P-Purchase | A | 8,006 | 7.63 | 61,054.00 |
2022-03-14 | Aquilo Capital Management, LLC | 10 percent owner | 5,223,498 | P-Purchase | A | 15,702 | 7.63 | 119,743.00 |
2022-02-28 | Aquilo Capital Management, LLC | 10 percent owner | 5,207,796 | P-Purchase | A | 15,104 | 9.53 | 143,931.00 |
2022-02-28 | Aquilo Capital Management, LLC | 10 percent owner | 5,192,692 | P-Purchase | A | 29,729 | 9.53 | 283,297.00 |
2022-02-18 | Aquilo Capital Management, LLC | 10 percent owner | 5,162,963 | P-Purchase | A | 14,828 | 9.24 | 137,039.00 |
2022-02-01 | Melnick David A. | officer: Chief Medical Officer | 62,081 | A-Award | A | 38,014 | 0.00 | 0.00 |
2022-02-01 | Melnick David A. | officer: Chief Medical Officer | 53,190 | A-Award | A | 53,190 | 11.18 | 594,664.00 |
2022-02-01 | Shukla Sath | officer: Chief Financial Officer | 62,081 | A-Award | A | 38,014 | 0.00 | 0.00 |
2022-02-01 | Shukla Sath | officer: Chief Financial Officer | 53,190 | A-Award | A | 53,190 | 11.18 | 594,664.00 |
2022-02-01 | Larkin Cristina | officer: Chief Operating Officer | 63,581 | A-Award | A | 38,014 | 0.00 | 0.00 |
2022-02-01 | Larkin Cristina | officer: Chief Operating Officer | 53,190 | A-Award | A | 53,190 | 11.18 | 594,664.00 |
2022-02-01 | Mahadevia Ankit | director, officer: CEO and President | 278,204 | A-Award | A | 134,168 | 0.00 | 0.00 |
2022-02-01 | Mahadevia Ankit | director, officer: CEO and President | 187,730 | A-Award | A | 187,730 | 11.18 | 2,098,821.00 |
2022-02-01 | Keutzer Timothy | officer: Chief Development Officer | 64,581 | A-Award | A | 38,014 | 0.00 | 0.00 |
2022-02-01 | Keutzer Timothy | officer: Chief Development Officer | 53,190 | A-Award | A | 53,190 | 11.18 | 594,664.00 |
2022-02-01 | JOSEPH TAMARA L | officer: Chief Legal Officer | 62,081 | A-Award | A | 38,014 | 0.00 | 0.00 |
2022-02-01 | JOSEPH TAMARA L | officer: Chief Legal Officer | 53,190 | A-Award | A | 53,190 | 11.18 | 594,664.00 |
2022-01-31 | Aquilo Capital Management, LLC | 10 percent owner | 5,148,135 | P-Purchase | A | 125,000 | 11.59 | 1,448,262.00 |
2022-01-24 | Aquilo Capital Management, LLC | 10 percent owner | 5,023,135 | P-Purchase | A | 1,599 | 10.89 | 17,418.00 |
2022-01-18 | Aquilo Capital Management, LLC | 10 percent owner | 5,021,536 | P-Purchase | A | 48,488 | 12.41 | 601,964.00 |
2022-01-10 | Aquilo Capital Management, LLC | 10 percent owner | 4,973,048 | P-Purchase | A | 8,867 | 12.93 | 114,609.00 |
2022-01-05 | Tregoning Kathleen | director | 4,428 | A-Award | A | 4,428 | 13.19 | 58,405.00 |
2022-01-05 | THOMAS FRANK E | director | 2,214 | A-Award | A | 2,214 | 13.19 | 29,203.00 |
2022-01-05 | VINK PATRICK V.J.J. | director | 2,214 | A-Award | A | 2,214 | 13.19 | 29,203.00 |
2021-12-31 | Aquilo Capital Management, LLC | 10 percent owner | 4,964,181 | P-Purchase | A | 125,000 | 15.75 | 1,969,025.00 |
2021-12-30 | Aquilo Capital Management, LLC | 10 percent owner | 4,839,181 | P-Purchase | A | 50,000 | 15.77 | 788,610.00 |
2021-12-29 | Aquilo Capital Management, LLC | 10 percent owner | 4,789,181 | P-Purchase | A | 75,493 | 14.64 | 1,105,263.00 |
2021-12-27 | Mahadevia Ankit | director, officer: CEO and President | 486,809 | M-Exempt | D | 8,000 | 5.90 | 47,200.00 |
2021-12-27 | Mahadevia Ankit | director, officer: CEO and President | 152,036 | M-Exempt | A | 8,000 | 5.90 | 47,200.00 |
2021-12-27 | Mahadevia Ankit | director, officer: CEO and President | 144,036 | S-Sale | D | 8,000 | 14.58 | 116,666.00 |
2021-11-11 | Tregoning Kathleen | director | 15,000 | A-Award | A | 15,000 | 16.91 | 253,650.00 |
2021-10-29 | Aquilo Capital Management, LLC | 10 percent owner | 4,713,688 | P-Purchase | A | 150,000 | 17.53 | 2,630,175.00 |
2021-10-11 | Tregoning Kathleen | director: | 0 | 0 | 0.00 | 0.00 | ||
2021-09-30 | Aquilo Capital Management, LLC | 10 percent owner | 4,563,688 | P-Purchase | A | 134,543 | 18.65 | 2,509,173.00 |
2021-09-14 | Aquilo Capital Management, LLC | 10 percent owner | 4,429,145 | P-Purchase | A | 2,156 | 18.49 | 39,872.00 |
2021-09-13 | Aquilo Capital Management, LLC | 10 percent owner | 4,426,989 | P-Purchase | A | 44,210 | 18.56 | 820,675.00 |
2021-09-09 | Aquilo Capital Management, LLC | 10 percent owner | 4,382,779 | P-Purchase | A | 24,749 | 18.50 | 457,792.00 |
2021-08-31 | Aquilo Capital Management, LLC | 10 percent owner | 4,358,030 | P-Purchase | A | 48,645 | 18.93 | 920,660.00 |
2021-08-30 | Aquilo Capital Management, LLC | 10 percent owner | 4,309,385 | P-Purchase | A | 44,042 | 17.87 | 786,859.00 |
2021-08-26 | Melnick David A. | officer: Chief Medical Officer | 24,067 | A-Award | A | 24,067 | 0.00 | 0.00 |
2021-08-26 | Mahadevia Ankit | director, officer: CEO and President | 144,036 | A-Award | A | 78,219 | 0.00 | 0.00 |
2021-08-26 | Larkin Cristina | officer: Chief Operating Officer | 25,567 | A-Award | A | 24,067 | 0.00 | 0.00 |
2021-08-26 | JOSEPH TAMARA L | officer: Chief Legal Officer | 24,067 | A-Award | A | 24,067 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.